237 related articles for article (PubMed ID: 9235677)
1. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
Nygaard HA; Høvding G
Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
[TBL] [Abstract][Full Text] [Related]
2. The safety of topical beta-blockers in glaucoma treatment.
Goldberg I
Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension.
Han JA; Frishman WH; Wu Sun S; Palmiero PM; Petrillo R
Cardiol Rev; 2008; 16(2):95-108. PubMed ID: 18281912
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
[TBL] [Abstract][Full Text] [Related]
5. Peyronie's disease following long-term use of topical timolol.
Ross JJ; Rahman I; Walters RF
Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
[No Abstract] [Full Text] [Related]
6. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker.
Shore JH; Fraunfelder FT; Meyer SM
J Clin Psychopharmacol; 1987 Aug; 7(4):264-7. PubMed ID: 3624510
[TBL] [Abstract][Full Text] [Related]
7. [New aspects on systemic adverse effects of ocular drugs].
Uusitalo H; Salminen L
Duodecim; 1998; 114(3):287-92. PubMed ID: 10895504
[No Abstract] [Full Text] [Related]
8. Potential side effects of timolol therapy in the treatment of glaucoma.
Zimmerman TJ; Leader BJ; Golob DS
Ann Ophthalmol; 1981 Jun; 13(6):683-9. PubMed ID: 7020551
[TBL] [Abstract][Full Text] [Related]
9. [Contact allergy to beta blockaders in eye drops: cross allergy?].
Giordano-Labadie F; Lepoittevin JP; Calix I; Bazex J
Ann Dermatol Venereol; 1997; 124(4):322-4. PubMed ID: 9739938
[TBL] [Abstract][Full Text] [Related]
10. Depression and topical ophthalmic beta adrenergic blockade.
Bourgeois JA
J Am Optom Assoc; 1991 May; 62(5):403-6. PubMed ID: 1687576
[TBL] [Abstract][Full Text] [Related]
11. [Contact allergy to eyedrops containing beta-blockers].
de Groot AC; van Ginkel CJ; Bruynzeel DP; Smeenk G; Conemans JM
Ned Tijdschr Geneeskd; 1998 May; 142(18):1034-6. PubMed ID: 9623207
[TBL] [Abstract][Full Text] [Related]
12. Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.
Tattersall C; Vernon S; Singh R
Eye (Lond); 2006 Feb; 20(2):221-5. PubMed ID: 15803169
[TBL] [Abstract][Full Text] [Related]
13. Cardiac safety of ophthalmic timolol.
Mäenpää J; Pelkonen O
Expert Opin Drug Saf; 2016 Nov; 15(11):1549-1561. PubMed ID: 27534869
[TBL] [Abstract][Full Text] [Related]
14. Ocular beta-blockers and systemic effects.
Fraunfelder FT
Arch Intern Med; 1986 Jun; 146(6):1073-4. PubMed ID: 2872865
[No Abstract] [Full Text] [Related]
15. Fatal respiratory arrest following timolol ophthalmic solution.
Malnick SD; Gelzer G; Attali M
MedGenMed; 2001 Mar; 3(2):12. PubMed ID: 11549961
[No Abstract] [Full Text] [Related]
16. [Atrioventricular block secondary to topical ophthalmic beta blockers].
Rubín López JM; Hevía Nava S; Veganzones Bayón A; Barriales Alvarez V
Rev Esp Cardiol; 1999 Jul; 52(7):532. PubMed ID: 10439680
[TBL] [Abstract][Full Text] [Related]
17. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
Taniguchi T; Kitazawa Y
Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
[TBL] [Abstract][Full Text] [Related]
18. Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004.
Jappe U; Uter W; Menezes de Pádua CA; Herbst RA; Schnuch A
Acta Derm Venereol; 2006; 86(6):509-14. PubMed ID: 17106597
[TBL] [Abstract][Full Text] [Related]
19. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
[TBL] [Abstract][Full Text] [Related]
20. Contact dermatitis to topical drugs for glaucoma.
Holdiness MR
Am J Contact Dermat; 2001 Dec; 12(4):217-9. PubMed ID: 11753897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
